⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8212140 | 1.00 | — | — | |
| SCHEMBL2386500 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL4636136 | 0.98 | HRH3 (0.41) | — | |
| Hydrochloric Acid SCHEMBL8391928 | 0.98 | HRH3 (0.41) | — | |
| Hydrochloric Acid SCHEMBL4636408 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL8393278 | 0.98 | HRH3 (0.41) | — | |
| SCHEMBL1994939 | 0.93 | — | — | |
| SCHEMBL26051501 | 0.91 | CYP2D6 (0.37) | — | |
| SCHEMBL22402217 | 0.91 | CYP2D6 (0.37) | — | |
| SCHEMBL640611 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 594 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612314-B2 | Halide perovskite nanocrystal array and its preparation | NORTHWESTERN UNIVERSITY (US) | 2026-04-28 | — | — | US | claimed |
| US-12473489-B2 | Scintillator material comprising a doped halide perovskite | LUXIUM SOLUTIONS, LLC (US) | 2025-11-18 | — | — | US | claimed |
| US-12351944-B2 | Two-dimensional perovskites for stable and efficient photovoltaic cells | NORTHWESTERN UNIVERSITY (US) | 2025-07-08 | — | — | US | claimed |
| US-20250176424-A1 | METHOD OF FORMING METAL ION DOPED HALIDE PEROVSKITE MEGALIBRARIE | NORTHWESTERN UNIVERSITY | 2025-05-29 | — | — | US | claimed |
| US-12310268-B2 | Neuromorphic memristor device based on vertically-oriented halide perovskite nanostructure and method of manufacturing the same | Seoul National Unviersity R&DBFoundation (KR) | 2025-05-20 | — | — | US | claimed |
| WO-2025076405-A1 | TWO-DIMENSIONAL PEROVSKITE TEMPLATES FOR DURABLE AND EFFICIENT PEROVSKITE SOLAR CELLS AND OPTOELECTRONIC DEVICES | WILLIAM MARSH RICE UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| US-20250115773-A1 | TWO-DIMENSIONAL PEROVSKITE TEMPLATES FOR DURABLE AND EFFICIENT PEROVSKITE SOLAR CELLS AND OPTOELECTRONIC DEVICES | WILLIAM MARSH RICE UNIVERSITY (US) | 2025-04-10 | — | — | US | claimed |
| CN-119789740-A | Perovskite solar cell based on tin-based perovskite thin film and preparation method | 西安交通大学 | 2025-04-08 | — | — | CN | claimed |
| US-20250002455-A1 | NEW N-PHENYLPYRROLAMIDE INHIBITORS OF DNA GYRASE AND TOPOISOMERASE IV WITH ANTIBACTERIAL ACTIVITY | UNIV LJUBLJANI (SI) | 2025-01-02 | — | — | US | claimed |
| CN-118829336-A | Perovskite layer preparation method, perovskite photovoltaic cell assembly and perovskite photovoltaic cell system | 天合光能股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-1735617-A | Quinazoline derivatives as SRC tyrosine kinase inhibitors | ASTRAZENECA AB (SE) | 2006-02-15 | — | — | CN | claimed |
| EP-1562955-A1 | QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS | Astrazeneca AB (SE) | 2005-08-17 | — | — | EP | claimed |
| EP-1546112-A2 | IMIDAZOLOPYRIDINES AND METHODS OF MAKING AND USING THE SAME | Biogen Idec MA Inc. (US) | 2005-06-29 | — | — | EP | claimed |
| US-6846827-B1 | Pyrimidine derivatives | ASTRAZENECA AB (SE) | 2005-01-25 | — | — | US | claimed |
| EP-1226126-B1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2005-01-05 | — | — | EP | claimed |
| WO-2004041829-A1 | QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS | ASTRAZENECA AB (SE) | 2004-05-21 | — | — | WO | claimed |
| WO-2004021989-A2 | IMIDAZOLOPYRIDINES AND METHODS OF MAKING AND USING THE SAME | BIOGEN IDEC MA INC. (US) | 2004-03-18 | — | — | WO | claimed |
| CN-1378537-A | Pyrimidine derivatives | ASTRAZENECA AB (SE) | 2002-11-06 | — | — | CN | claimed |
| EP-1226126-A1 | PYRIMIDINE DERIVATIVES | AstraZeneca AB (SE) | 2002-07-31 | — | — | EP | claimed |
| WO-2001027089-A1 | PYRIMIDINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-04-19 | — | — | WO | claimed |